Chemokine |
CCL5 |
Heparin |
40S loop (R44KNR47), α helix (K55, K56) |
18 μM |
Wang et al., 2011 |
|
|
CS |
40S loop(R44KNR47), N loop (R17, L19, I15) |
0.25 μM |
Deshauer et al., 2015 |
|
CXCL1 |
Heparin/HS |
N terminus(R8), N-loop (H19, K21),40S turn (K45, R48), β3-strand (R49), C-helix (K60, K61, K65) |
50 μM |
Sepuru and Rajarathnam, 2016; Sepuru et al., 2018b; Sepuru and Rajarathnam, 2019
|
|
|
CS/DS |
N terminus(R8), N-loop (H19, K21), 40S turn (R48), |
4 μM |
Sepuru and Rajarathnam, 2019 |
|
CXCL2 |
Heparin |
N-loop (R17, K21), 40S turn (K45), C-helix (K61, K65, K69) |
25 μM |
Sepuru et al., 2018b |
|
CXCL5 |
Heparin/HS |
N-loop (H23, K25), 40S turn (K49), β3 strand (K52), C-helix (Lys64, Lys65, Lys69, Lys76) |
30 μM |
Sepuru et al., 2016; Sepuru and Rajarathnam, 2019
|
|
|
CS/DS |
N-loop (H23, K25), 40S turn (K49), β3 strand (K52) |
3 μM |
Sepuru and Rajarathnam, 2019 |
|
CXCL7 |
Heparin |
N-loop (H15, K17), β3-strand(R44), C-helix (R54, K57, K61) |
— |
Brown et al., 2017 |
|
CXCL8 |
Heparin |
N-loop (K15, H18, K20, K23), C -helix (R60, K64, R68), β3-strand (R47), 50S loop (K54) |
μM |
Joseph et al., 2015 |
|
CXCL11 |
Heparin |
C- helix (K57SKQAR62) |
— |
Severin et al., 2010 |
|
CXCL12 |
Heparin |
C-helix (R12, A40), 20S loop (K24), 40S loop (N46) |
μM |
Laguri et al., 2011 |
|
CXCL13 |
HS |
C-helix (K60, R64, R67, H68), C-loop (K84, R85, R86) |
19 nM |
Monneau et al., 2017 |
|
CXCL14 |
Heparin |
10S loop(I12), β2-strand (I36, T37), 40S loop(K54), C -helix (R72), |
— |
Penk et al., 2019 |
|
|
CS/DS |
10S loop(I12), 40S loop(K54), C -helix (R72) |
— |
Penk et al., 2019 |
Growth factor |
FGF1 |
Heparin |
β1–β2 loop (N18), β8–β9 loop (N92), β10–β11 loop (K113), β11 strand (K118), β11–β12 loop (Q127, K128) |
nM |
Ogura et al., 1999 |
|
FGF2 |
Heparin |
β1 strand (K27), β1–β2 loop (N28), β8–β9 loop (N102), β10–β11 loop (R121), β11 strand (K126), β11–β12 loop (Q135, K136) |
nM |
Faham et al., 1996 |
|
FGF7 |
Heparin |
β3 strand (R18), 40s loop(N92), β10(N114), 110s loop(Q115), 120s loop (V120, K124, Q129, K130, T131) |
— |
Ye et al., 2001 |
Serpin |
AT III |
Heparin |
N-terminal end (K11, R13), A helix (R46, R47), D helix (K114, K125, R129, R132, K133, K136) |
20 nM |
Olson et al., 2002 |
Type II cytokines |
IL-10 |
Heparin/CS/DS |
D helix (K99, R102, R104, R106), 110S loop (R107, K117, K119) |
0.41 mM |
Künze et al., 2016 |
|
IFNγ |
Heparin |
C-terminal end (D1:K125TGKRKR131, D2:R137GRR140) |
1.63 nM |
Saesen et al., 2013 |
|
Roundabout 1 |
HS |
80s loop (K81), 130s loop (V133, H134, G135, R136, K137), βA strand (I167, R169) |
— |
Gao et al., 2016 |
Cytokine |
Pleiotrophin |
CS |
C-terminal TSR domain β-sheet (K60, K61, K69, K91, K92, K84, K86, K107) |
90 μM |
Ryan et al., 2016 |
Link protein |
CD44 |
HA |
β1 strand (K38), 40s loop (R41, Y42), 70s loop (R78, Y79), 90s loop (N100, N101), 150s loop (R150), β9 strand (R154), 160s loop(R162) |
μM |
Banerji et al., 2007 |
|
TSG-6 |
HA |
10s loop (K11, Y12), 40s loop (H45, C47), β3 strand (A49), β3 strand (Y59), 60s loop (V62, K63), 80s loop (Y78, R81) |
μM |
Higman et al., 2014 |
Viral pathogen |
viral CCL2 |
Heparin |
10s loop(R18), 40s loop (K45, R46, R48) |
113 mM |
Zhao and LiWang, 2010 |
Defensins |
Human β-defensin 2 |
Heparin/DS |
20s loop(R22RYK25), β3 strand (K39), 40s loop(K40) |
5 mM |
Seo et al., 2010 |
RNase A |
Eosinophil cationic protein |
Heparin |
α1 helix (R7, Q14, H15), β1 strand (Q40), loop4(H64), β6 strand(H128) |
15 μM |
García-Mayoral et al., 2013 |